Omega 3: The Most Effective Nutrient for Memory and Alzheimer’s

31 January, 2017 ,

Researchers at the University Laval, including Frederic Calon, one of the world’s leading experts in the field of neurological illnesses, have reviewed the literature on the use of Omega 3 to reduce cognitive decline associated with age related dementia and Alzheimer’s disease.

The first study mentioned is the MIDAS Study (Memory Improvement after DHA Study). In this study, 485 elderly healthy people (average age 70) took a 900mg supplement of DHA only (an Omega 3 usually associated with another, EPA) from algae, or a placebo made from corn and soy oil, during 24 weeks. The participants went through several memory and cognitive function tests. With the DHA supplement, they experienced improved memory and fewer errors compared to the placebo group.

The second study the researchers looked at concerned patients diagnosed with Alzheimer’s disease. This time, 402 participants received 2g DHA, or a placebo made from corn oil, during 18 weeks. The Alzheimer’s disease assessment scale – Cognitive subscale (ADAS-Cog) was used to measure progress. What’s more, researchers also took into account the presence of the genetic variation ApoE4 associated with a more rapid progression (the ApoE gene plays a fundamental role in the transport and metabolism of cellular lipids in the brain). In general, the study didn’t show any effect of DHA on those tests, including cerebral atrophy, except for the group that did not have the ApoE4 gene. In this subgroup, the use of DHA provoked significant changes, a slowing down of progression, etc. Take a look at this article to see how B vitamins can be useful in the presence of the ApoE4 gene.

Benefits for Menopausal Women

In a very recent study, menopausal women between the ages of 60 and 84, used a nutritional complex containing a good dose of DHA (1g DHA, 160mg EPA, 240mg Ginkgo biloba, 60mg phosphatidylserine, 20mg d-a tocopherol, 1mg folic acid and 20 µg B12). Their cognitive functions and memory improved, as well as their mobility.

autopromo_menopause_en

Omega 3: An Age Specific Effect?

Do Omega 3’s only have an impact on memory in the prevention of age-related cognitive decline? It appears not. In a group of young adults (18 to 25 years), taking Omega 3 (750mg DHA and 930mg EPA per day for six months) also improved memory. This improvement, as in the studies mentioned above, is proportional to the amount of DHA in red blood cells. However, interesting fact, researchers established, with the help of sophisticated imagery, that the mechanism of action doesn’t go via the neurotransmitters or the area of the brain affected by amphetamines.

Taking Omega 3 Supplements

At high doses, Omega 3’s are a tool to improve our brain functions. In fact, several studies also demonstrate their positive effect on depression, depression caused by the interferon used for treating Hepatitis C, and post-traumatic stress disorder. Seeing as fish are contaminated by mercury and other toxic substances, let’s eat it in moderation, and take Omega 3 supplements.

Wishing you the best of health!


References:

  1. Salem N Jr, Vandal M, Calon F. The benefit of docosahexaenoic acid for the adult brain in aging and dementia. Prostaglandine, Leukotrienes And Essential Fatty Acids. Jan 2015 ;92 :15-22 http://dx.doi.org/10.1016/j.plefa.2014.10.003 (Open access)http://www.plefa.com/article/S0952-3278(14)00169-0/abstract
  2. Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, Salem N Jr, Stedman M; MIDAS Investigators. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013. PubMed PMID: 20434961.ncbi.nlm.nih.gov/pubmed/20434961
  3. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.JAMA. 2010 Nov 3;304(17):1903-11. doi: 10.1001/jama.2010.1510. PubMed PMID: 21045096; PubMed Central PMCID: PMC3259852.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259852/
  4. Strike SC, Carlisle A, Gibson EL, Dyall SC. A High Omega-3 Fatty Acid Multinutrient Supplement Benefits Cognition and Mobility in Older Women: A Randomized, Double-blind, Placebo-controlled Pilot Study. J Gerontol A Biol Sci Med Sci. 2015 Aug 11. pii: glv109. [Epub ahead of print] PubMed PMID: 26265727.http://www.ncbi.nlm.nih.gov/pubmed/26265727
  5. Narendran R, Frankle WG, Mason NS, Muldoon MF, Moghaddam B. Improved working memory but no effect on striatal vesicular monoamine transporter type 2 after omega-3 polyunsaturated fatty acid supplementation. PLoS One. 2012;7(10):e46832. doi: 10.1371/journal.pone.0046832. PubMed PMID: 23056476; PubMed Central PMCID: PMC3463539. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0046832
  6. Su KP, Matsuoka Y, Pae CU. Omega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders. Clin Psychopharmacol Neurosci. 2015 Aug 31;13(2):129-37. doi: 10.9758/cpn.2015.13.2.129. PubMed PMID: 26243838.http://www.cpn.or.kr/journal/view.html?volume=13&number=2&spage=129
The following two tabs change content below.

Author

Jean-Yves Dionne

Jean-Yves Dionne is a pharmacist, educator, lecturer, scientific advisor, and consultant in natural health products (NHPs). He is a regular lecturer at the Universities of Montreal and Laval. He writes for many publications such as Montreal en Santé and sits on the editorial board of the Natural Medicine Journal, the official journal of the American Association of Naturopathic Physicians.

Jean-Yves Dionne

Latest posts by Jean-Yves Dionne (see all)

Articles

Leave a Reply

Your email address will not be published. Required fields are marked *